ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

UVFT UV Flu Technologies Inc (CE)

0.0001
0.00 (0.00%)
08 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
UV Flu Technologies Inc (CE) USOTC:UVFT OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.00 00:00:00

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

16/02/2016 9:36pm

Edgar (US Regulatory)




UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

 

FORM 12b-25

 

SEC FILE NUMBER

 

 

 

 

000-53306

 

 

 

 

 

 

 

NOTIFICATION OF LATE FILING

 

CUSIPNUMBER

918099 201

 

 

 

 

 

 

(Check one): o Form 10-K  o Form 20-F  o Form 11 -K  x Form 10-Q  o Form 10-D  o Form N-SAR

o Form N-CSR

For Period Ended:   December 31, 2015                                                       

o Transition Report on Form 10-K

o Transition Report on Form 20-F

o Transition Report on Form 11-K

o Transition Report on Form 10-Q

o Transition Report on Form N-SAR

For the Transition Period Ended:

 

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

 

PART I — REGISTRANT INFORMATION

 

 UV Flu Technologies, Inc.

Full Name of Registrant

 

 

Former Name if Applicable

 

250 Parkway Drive, Suite 150

Address of Principal Executive Office (Street and Number)

 

Lincolnshire, Illinois  60069

City, State and Zip Code

 

 

 

 

 

 

 

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

  

(a)

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense

x

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

  

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

  

  


  

 

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

 Registrant changed auditors recently and the audit will not be completed in time for a timely filing.  

 

  

  


  

 

(Attach extra Sheets if Needed)

PART IV — OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification

 

 

 

Michael S. Ross

 

(508)

 

362-5455

 

(Name)

 

(Area Code)

 

(Telephone Number)

 

 

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).  


Annual Report on Form 10-K for Fiscal Year ended 9/30/15

Yes o       No  x

 

 

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof ?

Yes o       No  x

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.



 

 

  


 

UV Flu Technologies, Inc.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date

February 16, 2016

By.   

  Michael S. Ross

 

 

 

 President, CEO, CFO, Principal Executive, Financial, Accounting Officer

 

 

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

 

  

ATTENTION

  

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

  

 

  

  


  



{Practice Areas/CORP/24045/00001/A3190121.DOC}


1 Year UV Flu Technologies (CE) Chart

1 Year UV Flu Technologies (CE) Chart

1 Month UV Flu Technologies (CE) Chart

1 Month UV Flu Technologies (CE) Chart

Your Recent History

Delayed Upgrade Clock